Smith & Nephew Unveils Long-Term Growth Targets Amid Q4 Earnings Momentum
Smith & Nephew has introduced ambitious financial targets for FY26 and FY28, signaling a definitive shift from its operational recovery phase to a sustained growth trajectory. The company’s Q4 results underscore the resilience of its Orthopaedics and Sports Medicine segments, supported by the continued rollout of the CORI robotics platform.